A detailed history of Rossmore Private Capital transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rossmore Private Capital holds 72,304 shares of MRK stock, worth $6.84 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
72,304
Previous 72,898 0.81%
Holding current value
$6.84 Million
Previous $8.28 Million 13.12%
% of portfolio
0.9%
Previous 1.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$96.31 - $114.76 $57,208 - $68,167
-594 Reduced 0.81%
72,304 $7.19 Million
Q3 2024

Nov 05, 2024

BUY
$111.15 - $128.97 $47,794 - $55,457
430 Added 0.59%
72,898 $8.28 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $96,440 - $103,575
-779 Reduced 1.06%
72,468 $8.97 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $24,912 - $29,028
-220 Reduced 0.3%
73,247 $9.66 Million
Q4 2023

Feb 07, 2024

SELL
$100.18 - $109.02 $15,227 - $16,571
-152 Reduced 0.21%
73,467 $8.01 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $3,706 - $4,115
36 Added 0.05%
73,619 $7.58 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $270,656 - $295,002
2,492 Added 3.51%
73,583 $8.49 Million
Q1 2023

May 02, 2023

SELL
$102.94 - $114.86 $28,617 - $31,931
-278 Reduced 0.39%
71,091 $7.56 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $32,615 - $41,817
-373 Reduced 0.52%
71,369 $7.92 Million
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $174,808 - $196,377
2,068 Added 2.97%
71,742 $6.18 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $164,558 - $186,535
1,971 Added 2.91%
69,674 $6.35 Million
Q1 2022

May 09, 2022

SELL
$73.51 - $82.4 $159,222 - $178,478
-2,166 Reduced 3.1%
67,703 $5.56 Million
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $1.21 Million - $1.52 Million
16,778 Added 31.6%
69,869 $5.36 Million
Q3 2021

Nov 08, 2021

BUY
$71.68 - $78.83 $38,348 - $42,174
535 Added 1.02%
53,091 $3.99 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $914 - $1,011
-13 Reduced 0.02%
52,556 $4.09 Million
Q1 2021

May 10, 2021

SELL
$68.86 - $81.11 $635,026 - $747,996
-9,222 Reduced 14.92%
52,569 $4.05 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $198,946 - $220,789
2,772 Added 4.7%
61,791 $5.06 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $780,098 - $884,247
10,660 Added 22.04%
59,019 $4.9 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $283,440 - $322,523
4,025 Added 9.08%
48,359 $3.74 Million
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $799,920 - $1.11 Million
12,625 Added 39.82%
44,334 $3.41 Million
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $987,515 - $1.11 Million
12,729 Added 67.07%
31,709 $2.88 Million
Q3 2019

Nov 05, 2019

BUY
$76.08 - $82.93 $521,148 - $568,070
6,850 Added 56.47%
18,980 $1.6 Million
Q2 2019

Aug 05, 2019

BUY
$69.84 - $81.59 $159,933 - $186,841
2,290 Added 23.27%
12,130 $1.02 Million
Q1 2019

Apr 30, 2019

SELL
$69.58 - $79.36 $3,061 - $3,491
-44 Reduced 0.45%
9,840 $818,000
Q3 2018

Oct 26, 2018

BUY
$57.69 - $67.84 $570,207 - $670,530
9,884 New
9,884 $701,000
Q1 2018

May 04, 2018

SELL
$50.96 - $59.23 $408,699 - $475,024
-8,020 Closed
0 $0
Q4 2017

Mar 15, 2018

BUY
$51.62 - $61.64 $413,992 - $494,352
8,020
8,020 $451 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $240B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.